AllianceBernstein’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,723
Closed -$71.8K 3245
2025
Q1
$71.8K Hold
14,723
﹤0.01% 3096
2024
Q4
$123K Sell
14,723
-4
-0% -$35 ﹤0.01% 3105
2024
Q3
$153K Hold
14,727
﹤0.01% 3074
2024
Q2
$290K Buy
14,727
+6,277
+74% +$126K ﹤0.01% 2922
2024
Q1
$216K Hold
8,450
﹤0.01% 2913
2023
Q4
$233K Buy
8,450
+568
+7% +$34.6K ﹤0.01% 2937
2023
Q3
$479K Hold
7,882
﹤0.01% 2595
2023
Q2
$519K Buy
7,882
+2,941
+60% +$215K ﹤0.01% 2622
2023
Q1
$314K Sell
4,941
-78
-2% -$8.91K ﹤0.01% 2756
2022
Q4
$695K Sell
5,019
-1,040
-17% -$147K ﹤0.01% 2469
2022
Q3
$767K Sell
6,059
-392
-6% -$44.4K ﹤0.01% 2429
2022
Q2
$534K Buy
6,451
+3,834
+147% +$297K ﹤0.01% 2654
2022
Q1
$254K Sell
2,617
-635
-20% -$83.8K ﹤0.01% 2927
2021
Q4
$650K Sell
3,252
-3,250
-50% -$767K ﹤0.01% 2630
2021
Q3
$1.61M Hold
6,502
﹤0.01% 2280
2021
Q2
$2.69M Buy
6,502
+4,784
+278% +$1.9M ﹤0.01% 2006
2021
Q1
$671K Sell
1,718
-786
-31% -$387K ﹤0.01% 2561
2020
Q4
$1.4M Sell
2,504
-3,918
-61% -$2.48M ﹤0.01% 2161
2020
Q3
$4.49M Buy
6,422
+3,960
+161% +$3.09M ﹤0.01% 1386
2020
Q2
$1.95M Sell
2,462
-3,300
-57% -$2.49M ﹤0.01% 1860
2020
Q1
$3.43M Buy
5,762
+1,590
+38% +$1.55M ﹤0.01% 1362
2019
Q4
$4.74M Buy
4,172
+2,162
+108% +$2.35M ﹤0.01% 1456
2019
Q3
$2.39M Sell
2,010
-1,351
-40% -$2.06M ﹤0.01% 1819
2019
Q2
$5.54M Buy
3,361
+727
+28% +$1.26M ﹤0.01% 1361
2019
Q1
$5.37M Buy
2,634
+262
+11% +$461K ﹤0.01% 1346
2018
Q4
$3.05M Sell
2,372
-21,731
-90% -$33.3M ﹤0.01% 1583
2018
Q3
$45.6M Sell
24,103
-720
-3% -$1.49M 0.03% 555
2018
Q2
$50.5M Buy
24,823
+2,882
+13% +$6.57M 0.04% 501
2018
Q1
$48.5M Buy
21,941
+14,810
+208% +$37.7M 0.04% 491
2017
Q4
$16.5M Buy
7,131
+1,001
+16% +$2.03M 0.01% 833
2017
Q3
$10.9M Sell
6,130
-361
-6% -$504K 0.01% 921
2017
Q2
$8.83M Sell
6,491
-137
-2% -$165K 0.01% 969
2017
Q1
$7.8M Buy
6,628
+2,211
+50% +$2.26M 0.01% 1002
2016
Q4
$3.53M Buy
4,417
+77
+2% +$61.1K ﹤0.01% 1416
2016
Q3
$3.81M Sell
4,340
-54
-1% -$39.1K ﹤0.01% 1288
2016
Q2
$2.46M Buy
4,394
+2,886
+191% +$1.63M ﹤0.01% 1527
2016
Q1
$830K Buy
1,508
+16
+1% +$9.83K ﹤0.01% 2201
2015
Q4
$1.24M Sell
1,492
-15
-1% -$15K ﹤0.01% 1993
2015
Q3
$1.67M Buy
1,507
+40
+3% +$72.9K ﹤0.01% 1794
2015
Q2
$3.2M Sell
1,467
-1,546
-51% -$3.15M ﹤0.01% 1400
2015
Q1
$4.71M Buy
3,013
+296
+11% +$391K ﹤0.01% 1149
2014
Q4
$3.23M Buy
2,717
+424
+18% +$283K ﹤0.01% 1391
2014
Q3
$1.07M Buy
2,293
+54
+2% +$24.9K ﹤0.01% 2153
2014
Q2
$1.12M Buy
2,239
+2,235
+55,875% +$716K ﹤0.01% 2178
2014
Q1
$1K Hold
4
﹤0.01% 3516
2013
Q4
$1K Hold
4
﹤0.01% 3318
2013
Q3
$2K Buy
+4
New +$1.49K ﹤0.01% 3227

Other funds holding BLUE

AllianceBernstein's BLUE Position: Q2 2025 in Review

AllianceBernstein sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 14,723 shares — an estimated $71.8K sold.

AllianceBernstein first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $50.5M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • AllianceBernstein reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 14,723 bluebird bio shares in Q2 2025, an estimated $71.8K.
  • AllianceBernstein first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • AllianceBernstein's bluebird bio position peaked at $50.5M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.